Cargando…

Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India

We conducted a cross-sectional survey to estimate the seroprevalence of IgG against severe acute respiratory syndrome coronavirus 2 in Chennai, India. Among 12,405 serum samples tested, weighted seroprevalence was 18.4% (95% CI 14.8%–22.6%). These findings indicate most of the population of Chennai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selvaraju, Sriram, Kumar, Muthusamy Santhosh, Thangaraj, Jeromie Wesley Vivian, Bhatnagar, Tarun, Saravanakumar, Velusamy, Kumar, Chethrapilly Purushothaman Girish, Sekar, Krithikaa, Ilayaperumal, Ezhilarasan, Sabarinathan, Ramasamy, Jagadeesan, Murugesan, Hemalatha, Masanam Sriramulu, Murhekar, Manoj Vasant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853587/ https://www.ncbi.nlm.nih.gov/pubmed/33496222 http://dx.doi.org/10.3201/eid2702.203938

Ejemplares similares

Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020
por: Vivian Thangaraj, Jeromie Wesley, et al.
Publicado: (2021)

Epidemiology of COVID-19 and effect of public health interventions, Chennai, India, March–October 2020: an analysis of COVID-19 surveillance system
por: M, Jagadeesan, et al.
Publicado: (2022)

Characterization of memory T cell subsets and common γ−chain cytokines in convalescent COVID‐19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2022)

Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2022)

Implementing Serosurveys in India: Experiences, Lessons Learned, and Recommendations
por: Hasan, Alvira Z., et al.
Publicado: (2021)

Experiences, Challenges, and Lessons Learned During Implementation of a Remote Monitoring Program for Home-Isolated COVID-19 Patients in Chennai, India
por: Ganeshkumar, Parasuraman, et al.
Publicado: (2023)

COVID-19 testing, timeliness and positivity from ICMR’s laboratory surveillance network in India: Profile of 176 million individuals tested and 188 million tests, March 2020 to January 2021
por: Ponnaiah, Manickam, et al.
Publicado: (2021)

Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

Enhanced SARS-CoV-2-Specific CD4(+) T Cell Activation and Multifunctionality in Late Convalescent COVID-19 Individuals
por: Pavan Kumar, Nathella, et al.
Publicado: (2022)

Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India
por: Salvi, Neha, et al.
Publicado: (2022)

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

Occurrence of hepatitis B virus genotype B and B + C mixed infections in Chennai, South India
por: Koli, Suneeta, et al.
Publicado: (2013)

Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2021)

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey
por: Murhekar, Manoj V, et al.
Publicado: (2021)

Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield(TM)) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021
por: Murali, Sharan, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
por: Murhekar, Manoj V., et al.
Publicado: (2020)

Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2021)

COVID-19 serosurveys for public health decision making
por: Murhekar, Manoj V, et al.
Publicado: (2021)

Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018–2020
por: Murhekar, Manoj V, et al.
Publicado: (2022)

Clinical Outcomes among Asymptomatic or Mildly Symptomatic COVID-19 Patients in an Isolation Facility in Chennai, India
por: Krishnasamy, Narayanasamy, et al.
Publicado: (2021)

Scrub Typhus as a Cause of Acute Encephalitis Syndrome, Gorakhpur, Uttar Pradesh, India
por: Mittal, Mahima, et al.
Publicado: (2017)

Recovery of Memory B-cell Subsets and Persistence of Antibodies in Convalescent COVID-19 Patients
por: Rajamanickam, Anuradha, et al.
Publicado: (2021)

COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India
por: Jaiswal, Anoop, et al.
Publicado: (2021)

Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
por: Raju, Mohan Kumar, et al.
Publicado: (2022)

Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study
por: Murhekar, Manoj V., et al.
Publicado: (2021)

Knowledge, attitude, and practice towards face mask use among residents of Greater Chennai Corporation, India, March 2021
por: Nagarajan, Ramya, et al.
Publicado: (2022)

Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019–20
por: Shanmugasundaram, Devika, et al.
Publicado: (2021)

Role of Orthopantamograph in Forensic Identification: A Retrospective Study Among Chennai Population
por: Rajkumari, Sriraman, et al.
Publicado: (2019)

Exploration of population ecological factors related to the spatial heterogeneity of dengue fever cases diagnosed through a national network of laboratories in India, 2017
por: Joshua, Vasna, et al.
Publicado: (2020)

Socio-demographic profile of HIV/AIDS patients at ART centres in Chennai
por: Uma, T, et al.
Publicado: (2012)

An influence of dew point temperature on the occurrence of Mycobacterium tuberculosis disease in Chennai, India
por: Krishnan, Rajendran, et al.
Publicado: (2022)

Prevalence of SCCmec types among Methicillin resistant Coagulase negative Staphylococci isolated from HIV patients in Chennai, South India
por: Saravanan, Murugesan, et al.
Publicado: (2014)

Dengue Serosurvey in Sint Eustatius
por: Leslie, Teresa, et al.
Publicado: (2014)

Locally Advanced Breast Cancer (LABC): Real-World Outcome of Patients From Cancer Institute, Chennai
por: Dhanushkodi, Manikandan, et al.
Publicado: (2021)

IANCON, Chennai, 2017
por: Khadilkar, Satish V
Publicado: (2017)

The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India
por: Ananthakrishnan, Ramya, et al.
Publicado: (2020)

Evaluation of Gynecologists' Awareness About Oral Health Condition During Pregnancy in Chennai City
por: Paneer, Silambarasan, et al.
Publicado: (2019)

Seven years of the field epidemiology training programme (FETP) at Chennai, Tamil Nadu, India: an internal evaluation
por: Bhatnagar, Tarun, et al.
Publicado: (2012)

Hepatitis E in Bangladesh: Insights From a National Serosurvey
por: Azman, Andrew S, et al.
Publicado: (2021)

Community voices around COVID-19 vaccine in Chennai, India: A qualitative exploration during early phase of vaccine rollout
por: Kumar, Muthusamy Santhosh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_unlt1hhpvrksnq6dl1b7lt5ppl